pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
GLP-1 receptor · news · pharmadog
← back to GLP-1 receptor
News · GLP-1 receptor
471
stories
Jun 5, 26
STAT+: Newer GLP-1s, pushback on research cuts, and a protest
stat
Jun 5, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jun 5, 26
Texas AG investigating energy drinks
stat
Jun 5, 26
STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
stat
Jun 4, 26
STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
stat
Jun 4, 26
STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
stat
Jun 4, 26
STAT+: Utah Medical Board scolded for going rogue with AI criticism
stat
Jun 4, 26
STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
stat
Jun 3, 26
What it will take for more employer GLP-1 coverage
endpoints
Jun 3, 26
STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
stat
Jun 2, 26
Opinion: The virtual end of the doctor’s office waiting room
stat
Jun 1, 26
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
stat
Jun 1, 26
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
stat
Jun 1, 26
CDC says containing the spread of Ebola is top priority
stat
Jun 1, 26
Lilly licenses GLP-2 asset from Korean biotech Hanmi for $75M upfront
endpoints
Jun 1, 26
2026 Orphan Drugs Report: A safe(r) passage amid stormy waters?
biopharma dive
Jun 1, 26
Opinion: The military’s medical corps has a serious recruitment problem
stat
Jun 1, 26
Opinion: Medical schools diversified. So where are all the diverse doctors?
stat
Jun 1, 26
STAT+: Medicare still won’t say how much covering obesity drugs will cost
stat
May 29, 26
Which vaccines will curb the Ebola outbreak? WHO debates
stat
May 29, 26
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
stat
May 28, 26
Lilly obesity meds Foundayo and Zepbound to gain CVS coverage
endpoints
May 28, 26
For wearables, it’s a GLP-1 world
endpoints
May 28, 26
CVS obesity drug deal puts Lilly on equal footing with Novo
biopharma dive
May 19, 26
STAT+: Dexcom CEO hints at future uses for CGM
stat
May 18, 26
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
biopharma dive
May 18, 26
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
stat
May 15, 26
FDA hold puts Aardvark Prader-Willi drug in limbo
biopharma dive
May 15, 26
India’s pharma industry is going global. But can it catch up to China?
biopharma dive
May 14, 26
Dr Jones on the Protective Benefit and Tolerability of GLP-1 Agonists vs Aspirin for CRC Prevention
onclive
← prev
page 15 of 16
next →